Delivery Order 36F79720D0099-36C24522N0628
Award Date 7/21/22
Potential Completion Date 7/29/22
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Riverwoods, IL 60015, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Otsuka America Pharmaceutical Inc. was awarded an $11,451.76 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of JYNARQUE 90MG-30MG to Clarksburg, West Virginia with a completion date of November 2, 2022. The contract was awarded on October 28, 2022 and utilizes pricing under GSA Schedule FSS-61-IB, with no...
- Otsuka America Pharmaceutical Inc. was awarded a $12,224.60 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order, to be completed by May 30, 2023, is for the drug JYNARQUE to support healthcare services provided by VISN 21 facilities located in Potomac, Maryland. No set-aside designation was applied to this order, which was...
- Otsuka America Pharmaceutical Inc. was awarded an $11,425.69 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the provision of JYNARQUE patient medication pharmacy orders to the Pittsburgh, PA area. No set-aside designation was applied to this order, which is associated with the larger Pharmaceuticals and Drugs GSA Schedule...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $12,559.90 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Otsuka America Pharmaceutical Inc. The firm fixed price order is for the drug JYNARQUE 90MG-30MG and has a completion date of January 12, 2024. Performance will take place in Pittsburgh, Pennsylvania under Master Contract FSS-61-IB, which provides pharmaceutical products and services to support...
- Otsuka America Pharmaceutical Inc. was awarded a $12,195.72 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order, which does not have a set-aside designation, is for the delivery of JYNARQUE 60MG/30MG to a location in Pittsburgh, Pennsylvania. Performance is required no later than February 10, 2023. The FSS-61-IB schedule...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 5 (VISN 5), awarded a $10,303.55 delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 45mg on February 5, 2021, with an ultimate completion date of February 10, 2021. This firm-fixed price delivery order, issued without a set-aside designation, was performed at the contractor's location in Riverwoods, Illinois. Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic...
- Otsuka America Pharmaceutical Inc. received a delivery order award valued at approximately $12.2K from the Department of Veterans Affairs' Veterans Integrated Service Network 5 for JYNARQUE (tolvaptan) 90mg/30mg tablets. The contract, awarded on August 5, 2023, with an ultimate completion date of August 11, 2023, operates under a firm-fixed-price model with no set-aside designation. This delivery order was issued under the company's larger Pharmaceuticals and Drugs Federal Supply Schedule...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a $10,298.57 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 60 mg on July 14, 2021, with an ultimate completion date of July 16, 2021. The delivery order was placed to the vendor's location in Riverwoods, Illinois. Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veterans. This award was...
- Otsuka America Pharmaceutical Inc. was awarded a delivery order valued at $10,298.57 by the Department of Veterans Affairs' Veterans Integrated Service Network 5 for Jynarque 45mg, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. Awarded on February 19, 2021, with completion targeted for September 20, 2021, this firm-fixed price contract represents a task order under the company's larger Blanket Purchase Agreement for Jynarque issued through...
- Otsuka America Pharmaceutical Inc. received a $10,034.63 firm fixed price delivery order from Veterans Integrated Service Network 5 for Jynarque 45 mg, a specialty pharmaceutical product used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract, awarded on September 25, 2020, with an ultimate completion date of September 30, 2020, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and did not utilize a set-aside designation. The...